Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Citi

Shocking moment a gust of wind almost knocked over world's 7th tallest building

In 1978 an undergraduate student at Princeton University cold called an architect’s office and helped prevent one of the world’s tallest buildings from being knocked over in New York

Daily Mirror

Should You Use a Credit Card Travel Portal?

Some credit cards come with travel portals, where you can redeem points and miles for trips. Is it the best option?

Kiplinger

3 Warren Buffett Bank Stocks That Yield More Than 3%

Concerns over heightened inflation pressures and the Federal Reserve's aggressive interest rate hikes have increased volatility. Given recession concerns, dividend stocks ensure a regular income stream and could be wise. Thus, Warren Buffett's dividend-paying bank stocks, The Bank of New York (BK), Citigroup (C), and U.S. Bancorp (USB), could be…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

Here's Why Citi Remains Bullish On Amazon Despite Knocking It Off Focus List

Citi analyst Ronald Josey considers Amazon.com Inc (NASDAQ: AMZN) vulnerable to softening consumer spending trends.

Benzinga

Warren Buffett Exits Wells Fargo And Buys Stake In Its Rival Bank

Berkshire Hathaway Inc (NYSE: BRK-B) bought $3 billion worth of shares in Citigroup Inc (NYSE: C) in Q1, giving the group a stake of about 2.8%, according to filings with regulators.

Benzinga

Citigroup: Buy, Sell, or Hold?

The shares of the renowned megabank Citigroup (C) have slumped more than 20% in price this year. Furthermore, with geopolitical issues taking a toll on the global economy and Wall Street seeing a risk of default by major banks, is C a smart investment now? Read on.

StockNews.com

Better Buy for 2022: Citibank vs. JPMorgan Chase

In this article I will analyze and compare Citigroup (C) and JPMorgan Chase (JPM) to determine which stock is currently a better investment.

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

Google Jumps The Crypto Bandwagon To Win Cloud Market From Alibaba, Amazon, Microsoft

Alphabet Inc’s (NASDAQ:GOOG) (NASDAQ:GOOGL) Google cloud unit formed a team to build services for developers running blockchain applications to tap the budding crypto market, CNBC reports. Former Citi executive James Tromans, who arrived at Google in 2019, will lead the product and engineering group. Google wants to offer back-end services to developers…

Benzinga

Citigroup says trader made error behind ‘flash crash’ in Europe

Inputting mistake led to suspension of trading on several markets after sudden steep falls

The Guardian - UK

Galera Posts Topline Data From Avasopasem Study In Chemoradiotherapy-Induced Esophagitis

Galera Therapeutics Inc (NASDAQ:GRTX) announced topline results from Phase 2a AESOP trial of avasopasem for severe acute radiation-induced esophagitis in lung cancer patients receiving concurrent chemoradiotherapy. Esophagitis is an early side effect of radiation or chemoradiation, causing pain, difficulties in swallowing with potential malnutrition, and dehydration. The trial enrolled 39 patients with unresectable…

Benzinga

Here's Why Analysts Remained Bullish On Western Digital Post Q3

Analysts reiterated their ratings on Western Digital Corporation's (NASDAQ: WDC)

Benzinga

Here's How Analysts Responded To Mastercard's Q1

Analysts maintained their conviction on Mastercard Incorporated (NYSE: MA)

Benzinga

Morning Brief: Top Financial Stories Dominating on Wednesday, April 27

Reuters Kellogg Sues British Government Over New Sugar Rules

Benzinga

FDA Plans To Convene AdComm For Ardelyx's Tenapanor For CKD Patients On Dialysis

The FDA's Office of New Drugs (OND), Center for Drug Evaluation and Research (CDER), has provided an interim response to Ardelyx Inc's (NASDAQ:ARDX) second level of appeal of the Complete Response Letter (CRL) for Xphozah. Ardelyx is seeking approval for Xphozah to control serum phosphorus in adult patients with chronic kidney disease (CKD) on…

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Asharq Al-Awsat

Gucci in Focus as China Lockdowns Weigh on Kering Q1 Sales

Disruptions from COVID-19 lockdowns in China cast a cloud on forecast-beating first-quarter sales from Gucci owner Kering on Thursday, even as the group pointed to sustained demand from the United States and Western Europe for its high-end fashion and leather goods labels. Group sales for the three months ending in…

Benzinga

Read How Analysts Reacted To Halliburton's Q1 Results

Analysts updated ratings and price target for Halliburton Company (NYSE:HAL) after Q1 results. Citi analyst Scott Gruber raised the price target to $48 (an upside of 19.6%) from $44 while maintaining the Buy rating on the shares. Gruber states that expectations for HAL were high coming into the quarter. The analyst utilizes 38% increments in…

Benzinga

Here's Why Citi Added Amazon To Focus List

Citi analyst Ronald Josey assumed coverage of Amazon.com Inc (NASDAQ:AMZN) with a Buy rating and price target of $4,100, down from $4,115 (29.7% upside). Josey also added the shares to the firm's Focus List, given its lead eCommerce, Online Advertising, and Cloud and operational efficiencies at its new Fulfillment Centers, physical retail location closures, and…

Benzinga

Citi Downgrades NXP Semiconductors - Read Why

Citi analyst Christopher Danely downgraded NXP Semiconductors NV (NASDAQ:NXPI) to Neutral from Buy with a price target of $190, down from $240 (6.8% upside), as his margin expansion thesis has played out. Danely derived his Buy thesis in February 2021 from the anticipation of superior margin/EPS upside and strength from the automotive end market.…

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Here's Why Analysts Remained Bullish On Microsoft Despite Price Target Cut

Two analysts remained bullish despite slashing their price targets on Microsoft Corp (NASDAQ:MSFT). Citigroup analyst Tyler Radke maintained Microsoft with a Buy and lowered the price target from $386 to $355 (24.8% upside). Amidst rising investor concerns around the sustainability of robust software demand and valuation multiples, Citi analyst Tyler Radke expects MSFT's results to…

The Guardian - UK

Monzo and beyond: How TS Anil put banking in a new light

The fintech startup’s boss always hoped it would make waves, but has only recently realised what his own career has meant to people of colour in banking

Benzinga

Why Bank Stocks Like U.S. Bancorp (USB), Goldman Sachs (GS) And Citigroup (C) Are Trading Higher Today

The Q1 earnings season is officially underway, with the major US banks reporting on their performance in the three months to the end of March.

Benzinga

Yet Another Analyst Sees Slowdown In PC Shipment Causing Headwind For Intel

Citi analyst Christopher Danely saw Intel Corp (NASDAQ: INTC) experience some headwinds as PC shipments fell below Citi's estimates.

Benzinga

Citi Is Bullish On Apple, Comments On Dividend, New Products and Market Value

Citi analyst Jim Suva saw "several positive drivers" for Apple Inc's (NASDAQ: AAPL) products and services despite geopolitical risks and consumer spending concerns.

Benzinga

HSBC Slashes Price Targets On Alibaba, Baidu Due to China's Covid Surge, Regulatory Crackdown

HSBC analyst Charlene Liu cut the price target on Baidu Inc (NASDAQ:BIDU) to $180 from $195 (31.3% upside) and kept a Buy rating on the shares. The analyst now assumes a worse impact from COVID-19 on the company's core ad and cloud businesses and margins, seeing a recovery only in Q4. Liu reduced the price…

Benzinga

Will Roblox Investors Have To Endure More Pain? Why This Investor Thinks 'All-Time Lows Are In Its Future'

Citigroup Inc (NYSE: C) gave the go-ahead to investors looking to enter the metaverse via Roblox Corp (NYSE: RBLX) on Thursday, but one investor thinks the analyst firm needs to snap back to reality. <

1 … 20 21 22 23

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.